Kohl's Corporation vs Nuwellis Inc — how do they compare? Kohl's Corporation trades at $18.85 (market cap $2.19B), while Nuwellis Inc trades at $1.36 (market cap $515.48K). The key difference: Kohl's Corporation is far larger — about 4248.5× Nuwellis Inc's market cap, and Kohl's Corporation pays a 2.59% dividend while Nuwellis Inc pays none. Which is the better fit depends on your goals.
| KSS | NUWE | |
|---|---|---|
Market Cap | $2.19B | $515.48K |
Sector | Consumer Cyclical | Technology |
52-Week High | $24.71 | $220.50 |
52-Week Low | $11.72 | $1.41 |
Enterprise Value | $8.29B | -$1.29M |
Dividend Yield | 2.59% | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
NUWE trades at $1.41, down 0.7% today, with a bearish technical signal despite oversold RSI readings. The company reported a net loss of $17.52 million on $8.27 million revenue in 2025, with negative cash flow from operations. Recent news highlights expansion in pediatric care and a $3.4 million direct offering in July 2026, alongside a reverse stock split executed in June 2026.
Outlook remains challenged by persistent losses and high cash burn, though revenue growth and product development offer potential. Risks include reliance on financing and competitive pressures. Analyst consensus is split evenly between Buy and Hold, reflecting cautious optimism amid fundamental weaknesses.
Trailing returns across standard periods
Latest headlines on both assets
Kohl's operates 1,165 department stores in 49 states that sell moderately priced private-label and national brand clothing, shoes, accessories, cosmetics, and home furnishings. Most of these stores are in strip centers. Kohl's also operates a large digital sales business. Women's apparel is Kohl's largest category, having generated 27% of its 2021 sales. The retailer, headquartered in Menomonee Falls, Wisconsin, opened its first department store in 1962.
Read more on KSS →Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →